Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Loading...
Files
Accepted Version
Date
2018-08-17
Authors
Boland, Barry
Yu, Wai Haung
Corti, Olga
Mollereau, Bertrand
Henriques, Alexandre
Bezard, Erwan
Pastores, Greg M.
Rubinsztein, David C.
Nixon, Ralph A.
Duchen, Michael R.
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
Published Version
Abstract
Neurodegenerative disorders of ageing (NDAs) such as Alzheimer disease, Parkinson disease, frontotemporal dementia, Huntington disease and amyotrophic lateral sclerosis represent a major socio-economic challenge in view of their high prevalence yet poor treatment. They are often called 'proteinopathies' owing to the presence of misfolded and aggregated proteins that lose their physiological roles and acquire neurotoxic properties. One reason underlying the accumulation and spread of oligomeric forms of neurotoxic proteins is insufficient clearance by the autophagic–lysosomal network. Several other clearance pathways are also compromised in NDAs: chaperone-mediated autophagy, the ubiquitin–proteasome system, extracellular clearance by proteases and extrusion into the circulation via the blood–brain barrier and glymphatic system. This article focuses on emerging mechanisms for promoting the clearance of neurotoxic proteins, a strategy that may curtail the onset and slow the progression of NDAs.
Description
Keywords
Neurodegenerative disorders of ageing (NDAs) , Neurotoxic proteins
Citation
Boland, B., Yu, W., Corti, O. et al. (2018) 'Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing', Nature Reviews Drug Discovery, 17, pp. 660–688. https://doi.org/10.1038/nrd.2018.109
Link to publisher’s version
Copyright
© 2018, Springer Nature Ltd. All rights reserved. This is a post-peer-review, pre-copyedit version of an article published in Nature Reviews Drug Discovery. The final authenticated version is available online at: https://doi.org/10.1038/nrd.2018.109